2 Top-Tier Dividend ETFs that Complement Each Other Well to Invest in Right Now

The Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Dividend Appreciation ETF (VIG) are complementary dividend ETFs that together offer both high income and growth potential. SCHD focuses on high-quality dividend-paying companies and offers higher yields, while VIG emphasizes dividend growth and has greater exposure to tech stocks like Apple and Microsoft, providing better stock price appreciation.

06/21/2026, 10:30 AM • The Motley Fool

Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider

The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion and Europe USD 6.25 trillion by 2035. Hospital services will dominate with 44% market share, while telehealth services will experience the fastest growth.

06/20/2026, 4:27 AM • GlobeNewswire

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock?

Mizuho analyst Ann Hynes raised her CVS Health price target to $115 per share, implying 13% upside from current levels. The article suggests CVS could see even greater upside potential, potentially reaching $150 per share if it achieves a valuation multiple similar to UnitedHealth Group, given its transformation into a diversified healthcare services company and expected double-digit earnings growth.

06/15/2026, 4:15 PM • The Motley Fool

Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit

The healthcare sector added 35,200 jobs in May, with ambulatory services leading at 25,700 positions and hospitals adding 6,000. This consistent job growth signals sustained demand for healthcare services and revenue opportunities for companies positioned in ambulatory care, managed care, and inpatient rehabilitation. Three stocks are highlighted as beneficiaries of this trend: UnitedHealth Group, HCA Healthcare, and Encompass Health.

06/15/2026, 1:36 PM • Investing

UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?

UnitedHealth Group has rebounded to a 52-week high with a 23% gain year-to-date, driven by better-than-expected Medicare Advantage reimbursement rates and improved margins. However, the stock remains down 34% from two years ago. The company faces significant dependency on government funding, with 44% of revenue from Medicare and Medicaid, creating uncertainty about future profitability if reimbursement rates decline.

06/11/2026, 4:32 PM • The Motley Fool

S&P 500 Selloff Looks More Like Rotation Than Market Breakdown

A stronger-than-expected May jobs report (172,000 payrolls vs. 80,000-105,000 forecast) triggered a market rotation rather than a broad selloff. The strong labor data pushed Treasury yields to 4.54%, reducing rate-cut expectations and hitting rate-sensitive tech stocks. While the Nasdaq fell 1.13% and semiconductor stocks cratered, the Russell 2000 surged 1.45% as money rotated into cyclicals and small caps. The Dow held near record highs, indicating broadening market participation rather than a systemic breakdown.

06/05/2026, 1:36 PM • Investing

UnitedHealth Positioned As AI Leader: Analyst

Morgan Stanley raised UnitedHealth's price target to $453 from $395 and named it a top pick, citing the company's leadership in AI adoption within managed care. The firm believes AI deployment could drive operational improvements, enhance medical loss ratios, and create new revenue opportunities, with potential for roughly 45% average earnings per share upside as efficiencies scale. UnitedHealth shares were trading near their 52-week high.

06/05/2026, 10:05 AM • Benzinga

Why Is UnitedHealth Stock Gaining Thursday?

UnitedHealth Group (UNH) surged 5.14% on Thursday following upgrades from Bank of America Securities (raising price target to $450) and Morgan Stanley (raising to $453). The gains were driven by improved Medicare Advantage rate announcements showing a 2.48% payment increase for 2027, easing medical cost trends, and potential AI-driven benefits for managed care organizations. The company also raised its fiscal 2026 adjusted EPS guidance to over $18.25.

06/04/2026, 1:11 PM • Benzinga

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

Warren Buffett and Greg Abel's Berkshire Hathaway portfolio is notably absent from the healthcare sector, holding only DaVita and recently exiting UnitedHealth Group. The article argues investors should consider healthcare independently, as it offers opportunities across multiple investment styles—from high-growth pharma/biotech plays like Eli Lilly to dividend-paying stalwarts like Johnson & Johnson and Abbott Laboratories that provide steady earnings and income.

06/03/2026, 12:05 PM • The Motley Fool

Berkshire Hathaway Made Some Major Portfolio Moves, but This One Was a Head-Scratcher. How Should Investors Take It?

Berkshire Hathaway's latest 13F filing reveals significant portfolio changes under new CEO Greg Abel, including exits from Visa, Mastercard, UnitedHealth Group, and Amazon. Most notably, Berkshire purchased 39.8 million shares of Delta Air Lines worth $3.28 billion, marking its return to the airline industry after previous losses during COVID-19. The move signals new management implementing different strategies, with Delta trading at attractive valuations below 10x earnings.

06/03/2026, 3:05 AM • The Motley Fool

Warren Buffett's Successor, Greg Abel, Just Sold UnitedHealth Group Stock. Is He Missing a Huge Opportunity?

Greg Abel, Berkshire Hathaway's new CEO, sold the company's entire 5.1 million-share stake in UnitedHealth Group in Q1 2026 as part of portfolio spring cleaning. While UnitedHealth shares have rallied over 40% since the sale, the author argues Abel made the right call given the stock's valuation risks and the company's ongoing turnaround challenges. Berkshire also exited positions in Amazon, Domino's, Mastercard, and Visa while increasing stakes in Alphabet and adding new positions in Delta Airlines and Macy's.

05/27/2026, 3:32 PM • The Motley Fool

Berkshire Hathaway Still Has Not Sold Its Bank of America Stake. Here's What That Tells Long-Term Investors.

Under new CEO Greg Abel, Berkshire Hathaway exited positions in Visa, Mastercard, and Amazon in Q1 2026, but maintained its large Bank of America stake (8% of portfolio, fourth-largest holding). The decision signals Berkshire's preference for fairly-valued traditional banks offering stability and income over expensive fintech companies, suggesting value-focused investing strategy.

05/27/2026, 12:30 PM • The Motley Fool

$663.3 Bn Revenue Cycle Management Market Trends and Global Forecasts Report 2026-2035

The global revenue cycle management (RCM) market is projected to grow at a CAGR of 11.51% from $200.1 billion in 2026 to $663.3 billion by 2035, driven by widespread EHR adoption, shift to value-based care models, and increasing use of AI and automation. North America holds the largest market share due to its complex healthcare system and advanced technology infrastructure. Key players include 3M, Change Healthcare, Optum, and McKesson, though high implementation costs and regulatory complexity present challenges.

05/21/2026, 4:57 AM • GlobeNewswire

Nvidia Earnings Could Decide Whether the AI Trade Still Holds

Markets faced mixed signals as geopolitical tensions eased on Iran sanctions reports, causing oil prices to reverse sharply lower. Bond yields surged globally on inflation concerns, with the 10-year Treasury hitting 4.631%. Nvidia's Wednesday earnings are positioned as the most critical event for the AI capital expenditure cycle, with options pricing a potential 7% move. Key corporate actions include NextEra-Dominion merger announcement, Berkshire Hathaway's portfolio restructuring under new CEO Abel, and Regeneron's failed Phase 3 trial.

05/18/2026, 1:12 PM • Investing

Why Is UnitedHealth Stock Trading Lower On Monday?

UnitedHealth Group (UNH) stock declined 3.05% in premarket trading Monday after Berkshire Hathaway disclosed it liquidated its entire 5 million share position in the healthcare company, held for less than a year. Despite the selloff, UnitedHealth reported strong Q1 2026 results with adjusted earnings of $7.23 (beating $6.58 estimate) and revenues of $111.721 billion. The company is also accelerating AI integration across operations, with plans to invest $1.5 billion in AI this year and reporting a 2-to-1 return on AI investments.

05/18/2026, 9:15 AM • Benzinga